The Latest Updates from ReSPECT Clinical Trials

COMING SOON: ReSPECT-LM at SABCS 2024

Dec 4, 2024

Exciting News: ReSPECT-LM Leptomeningeal Metastases Clinical Trial to be Showcased at SABCS 2024! Mark your calendars! Plus Therapeutics is thrilled to present groundbreaking data from our ReSPECT-LM Phase 1 clinical trial at the 2024 San Antonio Breast Cancer...

read more

COMING SOON: ReSPECT-LM MBC Patient Video

Dec 2, 2024

Inspiring Metastatic Breast Cancer Story: Marlyn’s Journey with Leptomeningeal Metastases The wait is almost over! This week, we are thrilled to release a brand new patient testimonial from one of our courageous ReSPECT-LM patients. In this powerful video, Marlyn...

read more

Happy Thanksgiving!

Nov 28, 2024

Thankful for the Oncology Community: Celebrating Patients, Caregivers, and Medical Advancements As we take time to reflect on the progress in the field of oncology, Plus Therapeutics extends our deepest gratitude to the patients, caregivers, and the dedicated medical...

read more

FORESEE Data at SNO 2024

Nov 22, 2024

Plus Therapeutics to Present Positive FORESEE Clinical Trial Data at SNO Annual Meeting in Houston Plus Therapeutics is thrilled to present groundbreaking results from the FORESEE Clinical Trial at the Society for Neuro-Oncology (SNO) Annual Meeting in Houston. The...

read more

Reminder: SNO Annual 2024 Symposium

Nov 22, 2024

Don’t Miss the SNO Annual Symposium Tomorrow – RSVP and Request a Recording! Reminder: The SNO Annual Meeting is TOMORROW (11/23)! If you can’t attend in person, or if you’d like to review the content later, you can RSVP for the presentation and request a recording of...

read more

JOIN US: SNO Annual 2024 Booth

Nov 21, 2024

Visit Plus Therapeutics at the SNO Annual Meeting in Houston – Booth #317/319 Reminder: Plus Therapeutics will be showcasing its groundbreaking radiotherapeutic advancements at the Society for Neuro-Oncology (SNO) Annual Meeting in Houston! Be sure to stop by our...

read more

CNSide at SNO 2024 – CSF Assay

Nov 21, 2024

Plus Therapeutics to Present Groundbreaking Data on CNSide™ Cerebrospinal Fluid Assay at SNO Annual Meeting in Houston Plus Therapeutics is excited to present new findings at the Society for Neuro-Oncology (SNO) Annual Meeting in Houston, focusing on our CNSide™...

read more

Lung Cancer Awareness Month 2024

Nov 19, 2024

Early Detection Saves Lives: Lung Cancer and Leptomeningeal Metastases Awareness Did you know that early detection of metastatic lung cancer can improve survival rates? This Lung Cancer Awareness Month, let’s take the opportunity to educate ourselves about the...

read more

JOIN US: SNO Annual 2024

Nov 18, 2024

Join Plus Therapeutics at the SNO Annual Meeting in Houston! Are you attending the 2025 Society for Neuro-Oncology (SNO) Annual Meeting in Houston this week? So are we! Plus Therapeutics is excited to showcase our latest research, symposium, oral presentations, and...

read more

RECAP: ABTA NYC Race with Plus Therapeutics

Nov 15, 2024

Plus Therapeutics at the ABTA Race in New York: Supporting Brain Cancer Awareness and Education Check out this photo of our dedicated patient advocacy team at the @the_ABTA race in New York last weekend! The Plus Therapeutics team was proud to support and participate...

read more

Listen Now: Q3 2024 Conference Call

Nov 15, 2024

ICYMI: Watch the Plus Therapeutics Q3 2024 Conference Call Webcast Replay Catch up on the latest financial results and updates from Plus Therapeutics! If you missed yesterday's conference call, don't worry – you can still access the webcast replay to hear about Plus...

read more

JOIN US: ABTA 5K for Recurrent Glioblastoma

Nov 9, 2024

Join Plus Therapeutics at the Upcoming 5K Event in New York! Meet Our Patient Advocacy Team Speaking about ReSPECT-GBM and Recurrent Glioblastoma Don’t miss the chance to visit the Plus Therapeutics booth at the ABTA NYC community 5K next week in New York! We’re...

read more

Leptomeningeal Metastases Symposium at SNO

Nov 8, 2024

You're Invited: Symposium on Novel Targeted Radiotherapies for Leptomeningeal Metastases at the 2025 Society for Neuro-Oncology Annual Meeting in Houston Join Us at the SNO Annual Conference to Explore Groundbreaking Advances in Leptomeningeal Metastasis Treatment...

read more

SpectronRx Partnership

Nov 6, 2024

BREAKING NEWS: Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy Press...

read more

ICYMI GBMRO Summit

Nov 4, 2024

What a great glioblastoma patient summit hosted by @glioblastomaresearch🎗️🧠 We extend our heartfelt thanks to the organization for hosting this event, as well as to all the patients and caregivers who stopped by our booth and came to Dr. Brenner's presentation to...

read more

GBMRO Summit Booth

Nov 1, 2024

Come by our booth this weekend at @glioblastomaresearch Glioblastoma Summit in Miami; also featuring a presentation by Dr. Andrew Brenner, MD, PhD on Saturday! Our clinical and patient advocacy team will be on-site to share educational material and answer your...

read more

ABTA 5K NYC

Oct 30, 2024

Come join us at the upcoming @the_abta 5K run in New York City! It’s not too late to register as we join together in the fight against brain cancer. Plus Therapeutics is proud to be a sponsor and will have a booth on-site to provide education about our clinical...

read more

SNO 2024 Announcement

Oct 29, 2024

Mark your calendars: We will be showcasing our Leptomeningeal Metastases programs at the 2024 SNO Annual Meeting in Houston, Texas! Plus Therapeutics will present data from the ReSPECT-LM Phase 1 clinical trial of Rhenium (186Re) Obisbemeda for leptomeningeal...

read more

GBMRO Summit Announcement

Oct 25, 2024

Join us at the upcoming @glioblastomaresearch Glioblastoma Patient Summit as Plus Therapeutics takes the stage! The summit will be held November 1-3 in Miami, FL, and include panel talks from neurosurgeons and neuro-oncologists as well as an opportunity to connect...

read more